Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
1073 Lymphokine-Activated Killer Cells Lyse Listeria-Infected Hepatocytes and Produce Elevated Quantities of Interferon-y Stephen H. Gregory, Xiaosui Jiang, and Edward J. Wing Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania The bulk of Listeria monocytogenes injected intravenouslyinto mice is taken up in the liver, where hepatocytes serve as the principal site of intracellular replication. NK cells have been implicated in host defenses to a variety of intracellular pathogens. To explore the role of NK cells in resistance to listerial infections of the liver, lymphokine-activated natural killer (LAK) cells were cocultured with Listeria-infected hepatocytes. The aspartate aminotransferase activity in the medium (evidence of cytotoxicity and hepatocyte damage) was elevated significantlyin these cultures. Conversely, the viability of intracellular Listeria organisms was reduced. Increased quantities of interferon-y (IFN1') were also detected. IFN-1' production by LAK cells was modulated by interleukin (lL)-2 and IL12.These findings suggest that the response of LAK cellsto infected hepatocytes may playa critical role in host defenses to Listeria organisms taken up in the liver. Listeria monocytogenes is a gram-positive bacterium capable of replicating intracellularly. Listeriosis in mice is an experimental model used widely to examine the factors that affect host resistance to intracellular pathogens [1]. NK cells have been implicated in nonspecific host defenses to a broad range of pathogens. In the case of Listeria organisms, the number of NK cells is increased significantly in the livers of mice infected intravenously (iv) [2]. The role of NK cells in host resistance is suggested by the fact that T cell-deficient (but NK-sufficient) mice, such as scid [3] and athymic nude [4], effectively control the early phase of listerial infections. Furthermore, scid mice depleted of NK cells before iv infection exhibit a 6-fold increase in the number of Listeria organisms recovered in the spleen on day 3 after infection [5]. Similarly, NK cell-depleted normal mice infected subcutaneously in the footpad exhibited marked increases in Listeria organisms subsequently recovered in the footpad and draining lymph nodes [6]. It has been suggested that a major function of NK cells in host defenses to intracellular pathogens may be to lyse infected host cells that otherwise serve as a protected environment for the growth of such organisms [7-10]. In addition, NK cells may synthesize and secrete soluble factors, such as interferon-y (lFN-y), that promote the resistance or antimicrobial activity of host cells [6, 10-12]. Most pathogens that enter the bloodstream are cleared by the liver [13-15]. In the case of Listeria, > 90% of the organisms Received 24 October 1995; revised 17 June 1996. Presented in part: 9th International Congress of Immunology, San Francisco, July 1995 (abstract 2010). This project was approved by the University of Pittsburgh Institutional Animal Care and Use Committee (assurance number A3I87-01). Grant support: NIH (DK-44367). Reprints or correspondence: Dr. Stephen H. Gregory, Dept. of Medicine, Montefiore University Hospital, 200 Lothrop St., Pittsburgh, PA 15213-2582. The Journal of Infectious Diseases 1996; 174:1073-9 © 1996 by The University of Chicago. All rights reserved. 0022-1899/96/7405-0024$0 1.00 recovered in the liver at 2 h after iv infection are associated with the parenchymal cells (hepatocytes) [16]. Hepatocytes constitute the principal site of listerial replication in the livers of nonimmune mice [16, 17]. Listeria organisms injected into immune animals, on the other hand, are taken up in the liver and rapidly eliminated [16]. Using a population oflymphokineactivated natural killer (LAK) cells, we undertook a series of in vitro experiments to explore the interaction ofNK cells and hepatocytes. Materials and Methods Bacteria. L. monocytogenes (EGD strain) was cultured and maintained as described [18]. Virulence of the organism was sustained by routine passage in mice. Listeria organisms harvested from cultures growing exponentially were used in the experiments described. Animals. Female C57BL/6J mice purchased from Jackson Laboratories (Bar Harbor, ME) were housed and cared for in accordance with guidelines set forth by the Institutional Animal Care and Use Committee, University of Pittsburgh. Hepatocytes and LAK cells were derived from animals that were between 2 and 4 months of age. Hepatocytes. Purified parenchymal cells (>96% viable hepatocytes) were obtained after perfusion of the liver with collagenase using the two-step method we reported previously [16, 19]. Hepatocytes were cultured in HEPES-buffered RPMI 1640 medium (BioWhittaker, Walkersville, MD) supplemented with I mM sodium pyruvate, 10- 7 M recombinant human insulin (Humulin R; Eli Lilly, Indianapolis), and 10% heat-inactivated fetal bovine serum (Sterile Systems, Logan, UT). Freshly isolated hepatocytes were analyzed by flow cytometry and found to be 50%-60% major histocompatibility complex (MHC) class I-positive and 0% MHC class II-positive; hepatocytes cultured for 12 h under nonadherent conditions were 50%-60% MHC class I-positive and 20%-30% MHC class II-positive. LAK cells. LAK cells were derived from nylon wool-monadherent, erythrocyte-depleted mouse splenocytes by culture in the presence of 1000 U/mL recombinant human interleukin (lL)-2 1074 Gregory et al. (Hoffmann-La Roche, Nutley, NJ) according to the methods described by Gunji et at. [20]. Cell cytometric analysis ofthe resultant population indicated that the majority of cells expressed surface markers characteristic of murine NK cells, that is, ~99% Thy1.2+ and ~88% NK-l.l + [20]. For experimental use, the cells were suspended in HEPES-buffered RPMI 1640 medium supplemented with 1 mM sodium pyruvate, 1 mM glutamine, 5 X 10- 5 M 2mercaptoethanol, 10% fetal bovine serum, 5 ;..tg/mL gentamicin, and the following cytokines unless noted otherwise: 30 U/mL IL2, 100 U/mL recombinant human tumor necrosis factor (TNF)-a (Genentech, South San Francisco, CA), and 50 pg/mL recombinant murine IL-12 (provided by Maurice Gately, Hoffmann-La Roche). Cocultures. Hepatocytes were seeded into 96-well tissue culture plates (2 X 104 cells/well) and the cells were incubated overnight. On the following day, the plates were inoculated with Listeria organisms, centrifuged at 200 g for 10 min at room temperature to facilitate contact between the bacteria and cells, and incubated for 4 h at 37°C. Gentamicin (5 ;..tg/mL final concentration) was then added to kill extracellular Listeria organisms, and the cells were incubated overnight. On the following day, LAK cells were added to the appropriate wells, and the cells were cocultured for the time periods indicated in the text. To determine whether direct contact between cell populations was required to stimulate IFN--y production by LAK cells, LAK cells and hepatocytes cocultured in the same well were separated by membrane inserts (0.45-;..tm Cyclopore membrane; Becton Dickinson Labware, Lincoln Park, NJ). Hepatocytes (lOs/well) in 24-well tissue culture plates were infected or not infected with 106 Listeria organisms. The next day, 106 LAK cells were added directly to the wells or to inserts placed in the wells. IFN--y in the culture supernates was assessed after 24 h of incubation. Cytotoxicity assay. To assess LAK cell-mediated lysis of hepatocytes, the cells were cocultured at various effector-to-target cell ratios under the conditions described above. Hepatocyte lysis was estimated from the level of aspartate aminotransferase (AST) activity in an aliquot of the culture supernate as described by Feutren et al. [21]. AST levels were quantified by the Clinical Chemistry Laboratory, University of Pittsburgh Medical Center, using an automated spectrophotometric assay. Percentage of specific cytotoxicity was calculated as follows: [(experimental AST - spontaneous AST)/(maximum AST - spontaneous AST)] X 100. Complete lysis of 2 X 104 hepatocytes yielded AST activity of 250-300 IU/L. Supernates derived from LAK cells cultured alone had <3 lUll AST activity. Lysis of infected hepatocytes resulted in the influx of culture medium and the death of intracellular Listeria organisms exposed to gentamicin. Viable Listeria organisms that remained were quantified as an alternative approach to assessing cytolysis of infected hepatocytes. At the end of the incubation period, the culture supernates were aspirated, the cell monolayers were lysed by treatment with 0.05% Triton X-IOO in trypticase soy broth, and the number of viable intracellular Listeria organisms released was estimated using a modification of the MTT assay described by Peck [22]. Briefly, 1 mg/mL (final concentration) MTT (Sigma, St. Louis) was added to the cell lysates, and the plates were incubated for 4 h at 37°C. The formazan product ofMTT metabolism was solubilized by the addition of an equal volume of 10% SDS in 0.01 N HCI, and the plates were incubated for an additional 18 h at 37°C. The plates were read on a microplate reader using a 570-nm test JlO 1996; 174 (November) 20 3 Listeria • 1 x 104 v 1 x 105 T 1 x 10 10 1:1 10:1 3:1 Effector:Target cell ratio Figure 1. Listeria-infected hepatocytes cocultured with LAK cells in presence of gentamicin exhibit marked reduction in viable intracellular bacteria. LAK cells and hepatocytes infected 24 h previously at concentrations shown were cocultured for 5 h in presence of 5 pg/ mL gentamicin. Data are mean ± SD absorbanceobtained fromtriplicate wells in single experiment;2 additional experimentsgave comparable results.In all cases, absorbanceobtained for infectedhepatocytes cocultured with LAK cells was significantly less than that obtained for infected hepatocytes cultured alone; P < .05 (one-way analysis of variance). filter and a 630-nm reference filter; wells containing hepatocytes with or without LAK cells and no Listeria organisms served as the blank. Alternatively, surviving intracellular Listeria organisms were estimated from the colonies that grew on trypticase soy agar plates inoculated with aliquots of diluted cell lysate. IFN-y detection by ELISA. IFN-y in the culture supemates was quantified by ELISA as described [23]. Statistical analysis. Results were analyzed using the SigmaStat statistics program (Jandel Scientific, San Rafael, CA). Multiple treatment groups were compared by analysis of variance followed by a Student-Newman-Keuls test. Differences at the P < .05 level were considered significant. Results Infected hepatocytes cocultured with LAK cells exhibit a marked reduction in viable, intracellular Listeria organisms. The addition of LAK cells to cultures of infected hepatocytes resulted in a marked reduction in the viability of intracellular Listeria organisms assessed in terms of MTT metabolism (figure I). This reduction was significant at an effector-to-target JID 1996;174 (November) LAK Cells Lyse Listeria-Infected Hepatocytes cell ratio of ~ 1:1 and was apparent in hepatocyte cultures inoculated with 103 , 104 , or 105 Listeria organisms. Similar results were obtained when the number of surviving intracellular Listeria organisms was estimated from the colonies that grew on trypticase soy agar plates inoculated with an aliquot of cell lysate (figure 2). It is pertinent to note that in the absence of LAK cells, the maximum number of intracellular bacteria was determined in cultures infected with 104 Listeria organisms/well. Between 90% and 95% of hepatocytes contained intracellular Listeria organisms at the time ofLAK cell addition as judged by Gram's staining. Infection with a larger dose, 105 organisms/well, resulted in an overall loss in hepatocyte viability and the death of bacteria exposed to gentamicin contained in the medium. LAK cells lyse Listeria-infected hepatocytes preferentially. The viability of intracellular bacteria correlated inversely with the cytotoxic activity expressed by LAK cells cocultured with Listeria-infected hepatocytes (figure 3). As the percentage of cytotoxicity increased with an increasing ratio of LAK cells to infected hepatocytes, MTT metabolism by intracellular Listeria organisms decreased concomitantly. Moreover, LAK cells 1075 200 <4 .q u ~ '>! 20 ~ ...o 0 0 -: 'r >-u u Su ,, ~ 0- CJ) c~ d- § (') 0 a a: r-.. ,, ~ ISO tJ'lt:::J ~ "-J 0 10 e , , , ,, ~ W 0 ~ ,,!' >< I-' 0 ! 1:1 ~ '" , ,, w '--' 3:1 10:1 Effector:Target cell ratio Figure 3. LAK cells lyse Listeria-infected hepatocytes preferentially. Uninfected hepatocytes (dashed rule) or hepatocytes infected with 104 Listeria/well (solid rule) were cocultured with LAK cells for 5 h. Data are mean ± SE derived from 6 wells in single experiment; comparable results were obtained in 5 similar experiments. LAK cells cocultured with Listeria-infected hepatocytes exhibited significantly more cytolytic activity (e) than did cells cocultured with uninfected hepatocytes; P = .042 (two-way analysis of variance). Infected hepatocytes cocultured with LAK cells (effector-to-target cell ratio ~ I) contained significantly fewer viable intracellular Listeria organisms (T) than did infected hepatocytes cultured alone; P < .05 (one-way analysis of variance). 1:1 3:1 10:1 Effector:Target cell ratio Figure 2. Viable intracellular Listeria organisms are reduced in cocultures that contain LAK cells and gentamicin (colony-forming unit assay). LAK cells and Listeria-infected hepatocytes were cocultured 8 h. Data are mean ± SE cfu obtained in single experiment; 2 additional experiments yielded similar results. Values obtained for infected hepatocytes cocultured with LAK cells at effector-to-target cell ratios ~ 3:I were significantly less than those obtained for infected hepatocytes cultured alone; P < .05 (one-way analysis of variance). lysed Listeria-infected hepatocytes preferentially. The percentage of cytotoxicity expressed by LAK cells was elevated in cocultures that contained infected, relative to those that contained uninfected, hepatocytes. This was particularly evident at lower effector-to-target cell ratios, that is, 3: I, at which nonspecific lysis of uninfected hepatocytes was limited. LAK cells cocultured with Listeria-infected hepatocytes produce elevated levels ofIFN-y. In addition to exhibiting cytolytic activity, LAK cells cocultured with Listeria-infected hepatocytes produced IFN-y. The amount of IFN-y produced was proportional to the number of LAK cells present. IFN-y was not detectable in supemates obtained from cultures of hepatocytes incubated in the absence of LAK cells (figure 4). Quantities of 2 X 105 LAK cells produced 5- to l O-fold more IFNy than did 2 X 104 LAK cells cocultured with hepatocytes under comparable conditions. In all cases, LAK cells cocultured with Listeria-infected hepatocytes secreted 2-4 times more IFN-y than did an equivalent number of LAK cells cocultured with uninfected hepatocytes. IL-2 and IL-12 act synergistically to stimulate IFN-y production by LAK cells cocultured with infected hepatocytes. JID 1996; 174 (November) Gregory et al. 1076 increase in IFN-y production. LAK cells incubated for 24 h in the presence or absence of 103 _10 5 bacteria produced comparable levels ofIFN-y (table I). In contrast, LAK cells cocultured with hepatocytes infected with the same number of Listeria organisms produced significantly more IFN-y (2- to 4-fold) than did LAK cells incubated with uninfected hepatocytes. Hepatocytes synthesize and secrete a variety of soluble factors, such as IL-I, IL-6, macrophage colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor, that possess immunomodulating activity [28, 29]. Soluble factors produced by hepatocytes did not contribute to the elevated levels ofIFN-y produced by LAK cells in our coculture system. Medium conditioned by the culture of uninfected or Listeriainfected hepatocytes had no effect on the subsequent production of IFN-y by LAK cells cultured alone (table 2). While there was no evidence to indicate that soluble factors secreted by hepatocytes affected IFN-y production by LAK Listeria/well • 0 3 v 1 x 10 4 .... 1 x 105 0 1 x 10 600 -e r-.. ~ 400 l:l..4 "'-" rZ I ~ ~ 200 o 2 6 20 4 LAK cells/well (x 10 ) Figure 4. IFN-y production by LAK cells cocultured with hepatocytes is modulated by LAK cell concentration and listerial infection. Hepatocytes (2 X 104/well) infected at concentrations indicated and increasing number of LAK cells were cocultured for 24 h. Values are mean IFN-y concentrations in supemates obtained from triplicate wells. Three experiments yielded comparable results. 150 -e ,--... ~ 0.- '-" 100 ?'-- The effects ofIL-2, IL-12, and TNF-a on the biologic activities expressed by NK and LAK cells are well-documented [5,20, 24-27]. IFN-y production by LAK cells cocultured with Listeria-infected hepatocytes was increased significantly by the presence ofIL-2 and IL-12. LAK cells incubated in the absence of exogenous cytokines produced a negligible quantity of IFNy (figure 5). While the addition of either IL-2 or IL-12 alone caused a detectable increase, optimal IFN-y production was attained only in cocultures that contained both IL-2 and IL-12. The effects of IL-2 and IL-12 were synergistic; the concentration of IFN-y in supemates derived from cultures treated with both cytokines was significantly greater than that expected if IL-2 and IL-12 had exerted additive effects on IFN-y production. In contrast to IL-2 or IL-12, the presence ofTNF-a failed to stimulate IFN-y production by LAK cells. Moreover, in comparable experiments (not shown), TNF-a had a slight inhibitory effect on the production of IFN-y by LAK cells cultured in the presence of either IL-2 or IL-12 alone. Contact with Listeria-infected hepatocytes stimulates IFNy production by LAK cells. Experiments were undertaken to examine the mechanisms that effected the elevated production ofIFN-y by LAK cells cocultured with Listeria-infected hepatocytes. Listeria organisms alone could not account for the Z I:I.4 50 CJ 0 g g. F N F ~ N ~ ...... ...... Q N + F N + F N N 'T.l t"'" ~ t"'" ~ + ..., Z 'T.l Q Figure 5. IFN-y production by LAK cells cocultured with Listeriainfected hepatocytes is modulated by interleukin (IL)-2 and -12. LAK cells (6 X 104/well) and hepatocytes infected 18 h previously with 104 Listeria organisms were cocultured for 24 h in presence or absence of 30 U/mL IL-2, 50 pg/mL IL-12, and 100 UlmL tumor necrosis factor (TNF)-a. Values are mean ± SE IFN-y concentrations in supemates obtained from 8 comparable wells. Two additional experiments yielded similar results. LAK Cells Lyse Listeria-Infected Hepatocytes JID ] 996; ]74 (November) Table 1. Hepatocytes stimulate IFN-y production by LAK cells. 1077 Table 3. Direct contactwith hepatocytes stimulates IFN-y production by LAK cells. IFN-y (pg/mL) Location of cells Inoculum/well 2 X 104 hepatocytes Without hepatocytes Well Control 103 104 105 2] 51 86 79 6 ± 5 6±3 4 ± 2 15 ± 9 HC + LAK L-HC + LAK HC L-HC ± 12* ± 10* ± 11* NOTE. Flat-bottom microtiter wells with or without hepatocytes were inoculated with Listeria organisms at concentration indicated. After 4 h of incubation, gentamicin was added and plates were incubated overnight. Next day, 6 X 104 LAK cells were added to each well; supernates were collected from 8 identical wells 24 h later. Values are mean ± SO TFN-y concentrations obtained in single experiment representative of 5 similar experiments. * Significantly greater than LAK cells cocultured with uninfected hepatocytes or cultured alone in wells inoculated with comparable concentration of Listeria organisms; P < .05 (one-way analysis of variance). cells, direct contact with Listeria-infected hepatocytes stimulated IFN-y production markedly. LAK cells cultured in contact with infected hepatocytes produced significantly more IFNy than did LAK cells cultured with uninfected hepatocytes (table 3). IFN-y production by LAK cells was diminished, however, when LAK cells and infected hepatocytes cocultured in the same well were separated by a membrane insert. Discussion NK cells have been implicated in host defenses to a broad range of microbial pathogens, including Legionella pneumophila [7, 11], Mycobacterium avium complex [30], Toxoplasma gondii [31], Shigella fiexneri [9, 12], Salmonella typhimurium [12], Leishmania major [32], Cryptococcus neoformans [33], and L. monocytogenes [3-6, 10, 34]. In the case of Listeria organisms, NK cells exhibit a transient 3- to 4-fold increase in the livers of mice by day 1 after infection iv with a sublethal Table 2. Soluble factors secreted by hepatocytes do not influence the production of IFN-y by LAK cells. IFN-y (pg/mL) Conditioned medium Control Hepatocytes Listeria-infected hepatocytes 1:10 1:4 31 ± 3 36 ± 4 33 ± 6 36 ± 2 27 ± 3 31 ± 2 Insert IFN-y (pg/mL) ±5 NOTE. LAK cells were suspended in medium supplemented with 1:10 or 1:4 dilutions of medium conditioned by 48-h culture of uninfected hepatocytes or hepatocytes infected with 104 Listeria organisms. Cells were seeded into flat-bottom microtiter plates at 6 X 104 LAK cells/well and cells were cultured for 24 h. Culture supemates were collected, and TFN-y production was quantified by ELISA. Values are mean ± SO IFN-y concentrations obtained from quadruplicate wells in single experiment; 3 experiments provided similar results. LAK LAK 142 420 221 265 ± ± ± ± 55 109* 88 68 NOTE. LAK cells and uninfected (HC) or Listeria-infected (L-HC) hepatocytes in 24-well tissue culture plates were incubated for 24 h together or separated by inserts. Data are mean ± SO concentrations of IFN-y in supernates collected from 6 wells in single experiment representative of 3 experiments. * Significantly greater than values obtained from cultures of LAK cells incubated with un infected hepatocytes or with infected hepatocytes separated by inserts; P < .05 (one-way analysis of variance). dose [2]. High levels of NK activity also occur among the nonadherent population of peritoneal exudate cells obtained from mice inoculated intraperitoneally with Listeria organisms [35]. The critical role of NK cells in host defenses to Listeria organisms is evidenced by the elevated replication of bacteria and the increased mortality of mice depleted ofNK cells before infection [5, 6]. The role of NK cells in host resistance to Listeria organisms remains to be delineated fully. It has been suggested that a principal function of NK cells may be the lysis of infected cells that otherwise serve as a protected environment for the growth of intracellular pathogens. Indeed, in the experiments reported here, LAK cells exhibited an elevated capacity to lyse Listeria-infected, relative to uninfected, hepatocytes. Lysis of infected hepatocytes correlated with a reduction in viable intracellular Listeria organisms that remained at the end of the incubation period. These results are consistent with previous reports describing the elevated cytolytic activity of human NK/ LAK cells incubated with Mycobacterium-infected monocytes [8], Legionella-infected macrophages [7], or Shigella-infected HeLa cells [9, 12]. Our findings, however, are inconsistent with a study demonstrating the failure of LAK cells to lyse either uninfected or Listeria-infected peritoneal macrophages [36]. The conflicting results obtained in the latter case may reflect the innate sensitivity of the infected target cells (i.e., hepatocytes vs. macrophages) to LAK cell lysis. IL-2, IL-12, and TNF-a are essential for optimal host defenses to Listeria organisms. Mice administered recombinant human IL-2 [37], recombinant human TNF-a [38], or recombinant murine IL-12 [39] near the time of infection exhibited elevated resistance to L. monocytogenes. Conversely, listeriosis was exacerbated in mice treated with either anti-mouse TNFa [5] or anti-mouse IL-12 [40]. It is likely that each of these cytokines has a multiplicity of effects on the response to listerial infection and the immune cell populations involved. In agreement with Gunji et al. [20], for example, we found that 1078 Gregory et al. IL-2 was crucial for the survival of LAK cells. LAK cells cultured overnight in the absence of IL-2 exhibited a marked reduction in cell viability (data not shown). lL-12 and TNFa, added singly or in combination, failed to reverse completely this loss in cell viability. In accordance with the reports of others [25, 40], we also found that IL-2 and IL-12 were essential for optimal production of IFN-y by LAK cells. While these cytokines had no consistent effect on the cytolytic activity exhibited by LAK cells in our coculture system (data not shown), IFN-y production by LAK cells was elevated significantly by a combination of IL2 and IL-12. Undoubtedly, the increased production of IFN-y observed in cultures that contained IL-2 and IL-12 was due in part to the enhanced viability of LAK cells incubated in the presence of exogenous cytokines (i.e., IL-2). Maximum IFNy production by LAK cells cocultured with Listeria-infected hepatocytes was also dependent on contact between the two cell populations and was not affected by soluble factors secreted by hepatocytes. IFN-y is critical for host defenses to Listeria monocytogenes. This is demonstrated by the fact that the proliferation of Listeria organisms is increased significantly in IFN-y-deficient mice [41] or mice administered monoclonal anti-IFN-y at the time of infection [19, 42]. Conversely, listerial replication is decreased markedly in animals administered IFN-y [19, 43,44]. IFN-y mRNA expression and/or IFN-y production assessed in the bloodstreams and organs of Listeria-infected mice are elevated significantly by day 1 after infection before the onset of antigen-specific T cell-mediated immunity [19, 45]. This latter observation has led others to suggest that NK cells may be responsible for the production of IFN-y detected early during the course of listerial infection [6]. Indeed, mice depleted of NK cells exhibited a 90% reduction in IFN-y-secreting cells assessed on day 1 after infection and a marked increase in the proliferation of Listeria organisms [6]. While the function of IFN-y in host defenses is not completely understood, it has been shown to stimulate the antimicrobial activity of macrophages [46], inhibit the replication of Listeria organisms within hepatocytes [19], and regulate the emergence of the Th1 subset of CD4 T lymphocytes during an immune response to infection [47, 48]. The parenchymal cells constitute the principal site of listerial replication in the liver. More than 90% of Listeria organisms recovered in the livers of mice at ~ 2 h after infection are associated with the hepatocyte population [16]. Our results suggest that the interaction between NK cells and infected hepatocytes may be a significant factor in host resistance to Listeria organisms expressed within the liver early during the course of infection. In addition to lysing these infected cells, infiltrating NK cells may produce elevated concentrations of IFN-y that are essential for the expression of nonspecific host resistance and the development a Thl cell-mediated immune response to infection. The mechanism(s) that enable LAK cells to distinguish between uninfected and Listeria-infected hepato- JID 1996; 174 (November) cytes remains to be determined. Lectin-like receptors, Ly-49 and NK-l.l, have been implicated in the non-MHC-restricted lysis of target cells by mouse LAK cells [49]. While the ligands recognized by these receptors have not been delineated, an inverse correlation exists between the amount of sialic acid expressed on the target cell surface and NK cell reactivity [50, 51]. Recently, Villanueva et al. [52] reported that the sialylation of glycoproteins on the surface of two macrophage cell lines was reduced significantly after listerial infection. Thus, the decreased sialylation of surface glycoproteins may account for the elevated reactivity of LAK cells cocultured with Listeriainfected hepatocytes. Acknowledgment We acknowledge the excellent technical assistance of Athanasia J. Sagnimeni. References I. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993; II: 129-63. 2. Goossens PL, Jouin H, Mi10n G. Dynamics of lymphocytes and inflammatory cells recruited in liver during murine listeriosis: a cytofluorimetric study. J Immunol 1991; 147:3514-20. 3. Bancroft GJ. Bosma MJ. Bosma GC, Unanue ER. Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction ofIa expression by a T cell-independent mechanism. J Imrnunol 1986; 137:4-9. 4. Newborg MF, North RJ. On the mechanism of T cell-independent antiListeria resistance in nude mice. J Immuno1 1980; 124:571-6. 5. Bancroft GJ. Sheehan KCF, Schreiber RD, Unanue ER. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol1989; 143:127-30. 6. Dunn PL, North RJ. Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun 1991; 59:2892-900. 7. Blanchard DK, Stewart WE II, Klein TW, Friedman H, Djeu JY. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila- infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immuno1 1987; 139:551-6. 8. Katz P, Yeager H Jr, Whalen G, et al. Natural killer cell-mediated lysis of Mycobacterium avium complex-infected monocytes. J Clin Immunol 1990; 10:71-7. 9. Klimpel GR, Niesel DW, Klimpe1 KD. Natural cytotoxic effector cell activity against Shigellaflexneri-infected HeLa cells. J Immunol 1986; 136:1081-6. 10. Guo Y, Niesel DW, Ziegler HK, Klimpel GR. Listeria monocytogenes activation of human peripheral blood lymphocytes: induction of nonmajor histocompatibility complex-restricted cytotoxic activity and cytokine production. Infect Immun 1992;60:1813-9. 11. Blanchard DK, Friedman H, Stewart WE II, Klein TW, Djeu JY. Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun 1988;56:1187-93. 12. Klimpe1 GR, Niesel DW, Asuncion M, Klimpel KD. Natural kiIler cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria. Infect Immun 1988;56:1436-41. 13. Mackaness GB. CeIlular resistance to infection. J Exp Med 1962; 116: 381 -406. JID 1996; 174 (November) LAK Cells Lyse Listeria-Infected Hepatocytes 14. Benacerraf B, Sebestyen M, Schlossman S. A quantitative study of the kinetics ofblood clearance ofp 32-labelled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp Med 1959; 110:27 -48. 15. Mims CA. The pathogenesis of infectious disease. 3rd ed. London: Academic Press, 1987:105-9. 16. Gregory SH, Barczynski LK, Wing EJ. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections . .I Leukoc BioI 1992; 51:421-4. 17. Rosen H, Gordon S, North R.I. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells . .I Exp Med 1989; 170:2737. 18. Wing EJ, Waheed A, Shadduck RK. Changes in serum colony stimulating factor (CSF) and monocytic progenitor cells during Listeria monocytogenes infection in mice. Infect Immun 1984;45:180-4. 19. Gregory SH, Wing EJ. IFN-gamma inhibits the replication of Listeria monocytogenes in hepatocytes. J ImmunoI1993;151:1401-9. 20. Gunji Y, Vujanovic NL, Hiserodt JC, Herberman RE, Gorelik E. Generation and characterization of purified adherent Iymphokine-activated killer cells in mice. J Immunol 1988; 142:1748-54. 21. Feutren G, Lacour B, Bach JF. Immune lysis of hepatocytes in culture: accurate detection by aspartate aminotransferase release measurement. .I Immunol Methods 1984;75:85-94. 22. Peck R. A one plate assay for macrophage bactericidal activity. J Immunol Methods 1985; 82: 131-40. 23. Jiang X, Gregory SH, Wing EJ. Hepatocytes can serve as accessory cells in the response of immune T lymphocytes to heat-killed Listeria monocytogenes. Infect Tmmun 1995; 63 :926- 33. 24. Wherry JC, Schreiber RD, Unanue ER. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun 1991; 59: 1709-15. 25. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor Q' are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Nat! Acad Sci USA 1993; 90:3725-9. 26. Gately MK, Warrier RR, Honasoge S, et al. Administration ofrecombinant TL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Tnt Immunol 1994;6:157-67. 27. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. J Exp Med 1991; 173:869- 79. 28. Tsukui T, Kikuchi K, Mabuchi A, et al. Production of macrophage colonystimulating factor by adult murine parenchymal liver cells (hepatocytes). J Leukoc Bioi 1992; 52:383-9. 29. Sakamoto T, Mabuchi A, Kuriya S, et al. Production of granulocytemacrophage colony-stimulating factor by adult murine parenchymal liver cells (hepatocytes). Reg Immunol 1991;3:260-7. 30. Harshan KV, Gangadharam PRJ. Depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 1991;59:2818-21. 31. Hunter CA, Abrams JS, Beaman MH, Remington JS. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell- independent regulation of resistance to T. gondii. Infect Immun 1993;61:4038-44. 32. Laskay T, RollinghoffT, Solbach W. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol 1993;23:2237 -41. 1079 33. Salkowski CA, Balish E. Role of natural killer cells in resistance to systemic cryptococcosis. J Leukoc Bioi 1991;50:151-9. 34. Emmerling P, Finger H, Hof H. Cell-mediated resistance to infection with Listeria monocytogenes in nude mice. Infect Immun 1977; 15:382-95. 35. Holmberg LA, Ault KA. Characterization of Listeria mono[ytogenesinduced murine natural killer cells. Immunol Res 1986;5:50-60. 36. Zychlinsky A, Karim M, Nonacs R, Young DE. A homogeneous population of lymphokine-activated killer (LAK) cells is incapable of killing virus-, bacteria-, or parasite-infected macrophages. Cell Immunoll990; 125:261-7. 37. Haak-Frendscho M, Young KM, Czuprynski C.I. Treatment of mice with human recombinant interleukin-Z augments resistance to the facultative intracellular pathogen Listeria monocytogenes. Infect Immun 1989; 57: 3014-21. 38. Kato K, Nakane A, Minagawa T, et al. Human tumor necrosis factor increases the resistance against Listeria infection in mice. Med MicrobioI Immunol 1989; 178:337-46. 39. Wagner RD, Steinberg H, Brown JF, Czuprynski CJ. Recombinant interleukin-12 enhances resistance to Listeria monocytogenes infection. Microb Pathog 1994; 17:175-86. 40. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. J Immunol 1994; 152: 1883-7. 41. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA . Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259: 1739-42. 42. Buchmeier NA, Schreiber RD. Requirement of endogenous interferongamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 1985; 82:7404-8. 43. Kiderlen AF, Kaufmann SHE, Lohmann-Matthes ML. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J lmmunol 1984; 14:964- 7. 44. Langermans JAM, van der Hulst MEB, Nibbering PH, van der Meide PH, van Furth R. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not the spleen and peritoneal cavity. Immunology 1992;77:354-61. 45. Ehlers S, Mielke MEA, Blankenstein T, Hahn H. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity. J Immunoll992; 149:3016-22. 46. Peck R. Gamma interferon induces monocyte killing of Listeria monocytogenes by an oxygen-dependent pathway; alpha- or beta-interferons by oxygen-independent pathways. J Leukoc Biol 1989;46:434-40. 47. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development ofTH I CD4+ T cells through IL-12 produced by Listeriainduced macrophages. Science 1993;260:547-9. 48. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. Pathogen-induced Th l phenotype development in CD4 + alpha beta-TCR transgenic T cells is macrophage dependent. Int Immunol 1993; 5:371-82. 49. Yokoyama WM, Seaman WE. The Ly-49 and NKR-PI gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993; 11:613-35. 50. Van Rinsum J, Srnets LA, Van Rooy H, Van den Eijnden DH. Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialo-oligosaccharides. Int J Cancer 1986;38:915-22. 51. Nabi ZF, Zucker-Franklin D, Baten A. Phorbol ester-induced loss ofmembrane sialic acid: implications for tumor cytolysis by natural killer cells. J Leukoc Bioi 1989;45:183-9. 52. Villanueva MS, Beckers CJM, Pamer EG. Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins. J Exp Med 1994; 180:2137-45.